The role of VWF in FVIII/VWF concentrates: biochemical characterization of three different plasma-derived factor VIII products

被引：0
|
作者：
Cristofaro, Raimondode [1 ]
Lancellotti, Stefano [1 ]
Filippis, Vincenzode [2 ]
Acquasaliente, Laura [2 ]
Valsecchi, Carla [3 ]
Garagiola, Sabella [3 ]
Peyvandi, Flora [3 ]
机构：
[1] Catholic Univ, Sch Med, Haemophilia & Thrombosis Ctr, Dpt Med Sci, Rome, Italy
[2] Univ Padua, Dpt Pharmaceut & Pharmacol Sci, Sch Med, I-35100 Padua, Italy
[3] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] Native analysis of plasma-derived clotting factor VIII concentrates: "Sponge effect" and contaminants
    Blasi, Barbara
    D'Amici, Gian Maria
    D'Alessandro, Angelo
    Zolla, Lello
    ELECTROPHORESIS, 2012, 33 (08) : 1292 - 1298
  • [42] Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
    Eduardo Megias-Vericat, Juan
    Bonanad, Santiagi
    Haya, Saturnino
    Rosa Cid, Ana
    Remedios Marques, Maria
    Monte-Boquet, Emilio
    Perez-Alenda, Sofia
    Querol, Felipe
    Bosch, Pau
    Luis Poveda, Jose
    HAEMOPHILIA, 2020, 26 : 19 - 19
  • [43] Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better
    Franchini, Massimo
    BLOOD TRANSFUSION, 2010, 8 (04) : 292 - 296
  • [44] In vitro model on thrombin generation of hemophilia A patient with inhibitors under simultaneous treatment with emicizumab, plasma-derived VWF/FVIII and rFVIIa
    Bravo, Maria-Isabel
    Raventos, Aida
    Perez, Alba
    Costa, Montserrat
    Willis, Todd
    HAEMOPHILIA, 2020, 26 : 16 - 16
  • [45] FACTOR-VIII INHIBITOR ASSAYS USING PLASMA-DERIVED FVIII VERSUS RECOMBINANT FVIII - A COMPARATIVE-STUDY
    HILLMANWISEMAN, C
    VITALE, C
    LUSHER, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 684 - 684
  • [46] ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates
    Peyvandi, Flora
    Mannucci, Pier Mannuccio
    Valsecchi, Carla
    Pontiggia, Silvia
    Bernstein, Jonathan
    Guazzini, Stefano
    Retzios, Anastassios
    BLOOD, 2012, 120 (21)
  • [47] Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate
    Oldenburg, J.
    Jimenez-Yuste, V.
    Peiro-Jordan, R.
    Aledort, L. M.
    Santagostino, E.
    HAEMOPHILIA, 2014, 20 (01) : 83 - 91
  • [48] Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors
    Jimenez-Yuste, V.
    Oldenburg, J.
    Rangarajan, S.
    Kurth, M. H.
    Bozzo, J.
    Santagostino, E.
    HAEMOPHILIA, 2016, 22 (01) : E71 - E74
  • [49] Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates
    Dingli, D
    Gastineau, DA
    Gilchrist, GS
    Nichols, WL
    Wilke, JL
    HAEMOPHILIA, 2002, 8 (05) : 629 - 634
  • [50] Allergic reaction in a cohort of haemophilia A patients using plasma-derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII
    Montalvao, S. A. L.
    Tucunduva, A. C.
    Siqueira, L. H.
    Sambo, A. L. A.
    Medina, S. S.
    Ozelo, M. C.
    HAEMOPHILIA, 2015, 21 (04) : E281 - E285
12345